Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

YFP-CL1 Citations (3)

Originally described in: Endoplasmic reticulum stress compromises the ubiquitin-proteasome system.
Menendez-Benito V, Verhoef LG, Masucci MG, Dantuma NP Hum Mol Genet. 2005 Oct 1. 14(19):2787-99.
PubMed Journal

Articles Citing YFP-CL1

Articles
Curcusone D, a novel ubiquitin-proteasome pathway inhibitor via ROS-induced DUB inhibition, is synergistic with bortezomib against multiple myeloma cell growth. Cao MN, Zhou YB, Gao AH, Cao JY, Gao LX, Sheng L, Xu L, Su MB, Cao XC, Han MM, Wang MK, Li J. Biochim Biophys Acta. 2014 Jun;1840(6):2004-13. doi: 10.1016/j.bbagen.2014.02.006. Epub 2014 Feb 15. PubMed
Amino-terminal arginylation targets endoplasmic reticulum chaperone BiP for autophagy through p62 binding. Cha-Molstad H, Sung KS, Hwang J, Kim KA, Yu JE, Yoo YD, Jang JM, Han DH, Molstad M, Kim JG, Lee YJ, Zakrzewska A, Kim SH, Kim ST, Kim SY, Lee HG, Soung NK, Ahn JS, Ciechanover A, Kim BY, Kwon YT. Nat Cell Biol. 2015 Jul;17(7):917-29. doi: 10.1038/ncb3177. Epub 2015 Jun 15. PubMed
TRIM11 activates the proteasome and promotes overall protein degradation by regulating USP14. Chen L, Zhu G, Johns EM, Yang X. Nat Commun. 2018 Mar 26;9(1):1223. doi: 10.1038/s41467-018-03499-z. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.